Focal liver lesion, incidental finding;Der zufällig entdeckte Leberrundherd

Deutsche Medizinische Wochenschrift

Volumn 137, Issue 41, 2012, Pages 2099-2116

  Dietrich, C F ^a   Jenssen, C ^b  

^a CARITAS KRANKENHAUS   (Germany)

^b Strausberg Wriezen and Brandenburg Institute for Clinical Ultrasound   (Germany)

Author keywords

Computed tomography; Contrast enhanced ultrasonography; Focal nodular hyperplasia; Guidelines; Hemangioma; Hepatocellular carcinoma; Liver metastases; Magnetic resonance imaging

Indexed keywords

INCIDENTAL FINDING; LIVER INJURY; REVIEW; ADULT; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; HEMANGIOMA; HUMAN; IMAGE ENHANCEMENT; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER TUMOR; MALE; METASTASIS; NODULAR HYPERPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE;

CONTRAST MEDIUM;

CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FOCAL NODULAR HYPERPLASIA; GUIDELINE ADHERENCE; HEMANGIOMA; HUMANS; IMAGE ENHANCEMENT; INCIDENTAL FINDINGS; LIVER DISEASES; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY; YOUNG ADULT;

EID: 84866870670     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0032-1305302     Document Type: Review

References (48)

1. Albrecht T, Blomley M, Bolondi L et al. Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall Med 2004;25:249-256
2. Anderson SW, Kruskal JB, Kane RA. Benign hepatic tumors and iatrogenic pseudotumors. Radiographics 2009;29:211-229
3. Barreiros AP, Piscaglia F, Dietrich CF. Contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): Comments on AASLD guidelines. J Hepatol 2012; ePub ahead of print
4. Bernatik T, Seitz K, Blank W et al. Unclear focal liver lesions in contrast-enhanced ultrasonography-lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors. Ultraschall Med 2010;31:577-581
5. Biecker E, Fischer HP, Strunk H et al. Benign hepatic tumours. Z Gastroenterol 2003;41:191-200
6. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011;53:1020-1022
7. Claudon M, Cosgrove D, Albrecht T et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008. Ultraschall Med 2008;29:28-44
8. Cui XW, Ignee A, Braden B et al. Biliary Papillomatosis and New Ultrasound Imaging Modalities. Z Gastroenterol 2012;50:226-231
9. Devine AS, Jackson CS, Lyons L et al. Frequency of incidental findings on computed tomography of trauma patients. West J Emerg Med 2010;11:24-27
10. Dietrich CF. Liver tumor characterization - comments and illustrations regarding guidelines. Ultraschall (Suppl) 2012;33:S22-S30
11. Dietrich CF, Cui XW, Barreiros AP et al. EFSUMB Guidelines 2011: Comment on emergent indications and visions. Ultraschall (Suppl) 2012;33:S39-S47
12. Dietrich CF, Cui XW, Boozari B et al. Contrast-enhanced ultrasound (CEUS) in the diagnostic algorithm of hepatocellular and cholangiocellular carcinoma. Ultraschall (Suppl) 2012;33:S57-S66
13. Dietrich CF, Cui XW, Ignee A. EFSUMB Guidelines 2011: Comments and illustrations. Ultraschall (Suppl) 2012;33:S11-S21
14. Dietrich CF, Maddalena ME, Cui XW et al. Liver tumor characterization - review of the literature. Ultraschall (Suppl) 2012;33:S3-S10
15. Dietrich CF, Nuernberg D. Lehratlas der interventionellen Sonographie. Stuttgart, New York, Thieme 2011
16. Dietrich CF, Serra C, Jedrejczyk M. EFSUMB European Course BookIn: Dietrich CF, Hrsg. London, European Federation of Societies for Ultrasound in Medicine and Biology 2012;27-55
17. Dietrich CF, Averkiou MA, Correas JM et al. An EFSUMB Introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for Quantification of Tumour Perfusion. Ultraschall Med 2012;33:344-351
18. Dietrich CF, Ignee A, Hocke M et al. Pitfalls and artefacts using contrast enhanced ultrasound. Z Gastroenterol 2011;49:350-356
19. Dietrich CF, Ignee A, Trojan J et al. Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A. Gut 2004;53:401-405
20. Dietrich CF, Kratzer W, Strobe D et al. Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. World J Gastroenterol 2006;12:1699-1705
21. Dietrich CF, Mertens JC, Braden B et al. Contrast-enhanced ultrasound of histologically proven liver hemangiomas. Hepatology 2007;45:1139-1145
22. Dietrich CF, Riemer-Hommel P. Challenges for the German Health Care System. Z Gastroenterol 2012;50:557-572
23. Dietrich CF, Schuessler G, Trojan J et al. Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. Br J Radiol 2005;78:704-707
24. Guang Y, Xie L, Ding H et al. Diagnosis value of focal liver lesions with SonoVue (R)-enhanced ultrasound compared with contrast-enhanced computed tomography and contrast-enhanced MRI: a meta-analysis. J Cancer Res Clin Oncol 2011;137:1595-1605
25. Hirche TO, Ignee A, Hirche H et al. Evaluation of hepatic steatosis by ultrasound in patients with chronic hepatitis C virus infection. Liver Int 2007;27:748-757
26. Hirche TO, Russler J, Schroder O et al. The value of routinely performed ultrasonography in patients with Crohn disease. Scand J Gastroenterol 2002;37:1178-1183
27. Ignee A, Piscaglia F, Ott M et al. A benign tumour of the liver mimicking malignant liver disease - cholangiocellular adenoma. Scand J Gastroenterol 2009;44:633-636
28. Ignee A, Weiper D, Schuessler G et al. Sonographic characterisation of hepatocellular carcinoma at time of diagnosis. Z Gastroenterol 2005;43:289-294
29. Karhunen PJ. Benign hepatic tumours and tumour like conditions in men. J Clin Pathol 1986;39:183-188
30. Mork H, Ignee A, Schuessler G et al. Analysis of neuroendocrine tumour metastases in the liver using contrast enhanced ultrasonography. Scand J Gastroenterol 2007;42:652-662
31. Nguyen BN, Flejou JF, Terris B et al. Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 1999;23:1441-1454
32. Nuernberg D, Ignee A, Dietrich CF. Aktueller Stand der Sonographie in der Gastroenterologie - Leber und Milz. Z Gastroenterol 2006;44:991-1000
33. Piscaglia F, Nolsoe C, Dietrich CF et al. The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med 2012;33:33-59
34. Schlottmann K, Klebl F, Zorger N et al. Contrast-enhanced ultrasound allows for interventions of hepatic lesions which are invisible on convential B-mode. Z Gastroenterol 2004;42:303-310
35. Schuessler G, Fellbaum C, Fauth F et al. der inflammatorische Pseudotumor - eine schwierige Differenzialdiagnose. Ultraschall Med 2006;27:273-279
36. Seitz K, Bernatik T, Strobel D et al. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI - a prospective comparison in 269 patients. Ultraschall Med 2010;31:492-499
37. Seitz K, Greis C, Schuler A et al. Frequency of tumor entities among liver tumors of unclear etiology initially detected by sonography in the noncirrhotic or cirrhotic livers of 1349 patients. Results of the DEGUM multicenter study. Ultraschall Med 2011;32:598-603
38. Seitz K, Strobel D, Bernatik T et al. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreilandertreffen 2008, Davos. Ultraschall Med 2009;30:383-389
39. Strobel D, Bernatik T, Blank W et al. Diagnostic accuracy of CEUS in the differential diagnosis of small (
40. Strobel D, Seitz K, Blank W et al. Contrast-enhanced ultrasound for the characterization of focal liver lesions - diagnostic accuracy in clinical practice (DEGUM multicenter trial). Ultraschall Med 2008;29:499-505
41. Strobel D, Seitz K, Blank W et al. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1, 349 liver lesions in contrast-enhanced ultrasound (CEUS). Ultraschall Med 2009;30:376-382
42. Trillaud H, Bruel JM, Valette PJ et al. Characterization of focal liver lesions with SonoVue-enhanced sonography: international multicenter-study in comparison to CT and MRI. World J Gastroenterol 2009;15:3748-3756
43. Trojan J, Hammerstingl R, Engels K et al. Contrast-enhanced ultrasound in the diagnosis of malignant mesenchymal liver tumors. J Clin Ultrasound 2010;38:227-231
44. Volk M, Strotzer M, Lenhart M et al. Frequency of benign hepatic lesions incidentally detected with contrast-enhanced thin-section portal venous phase spiral CT. Acta Radiol 2001;42:172-175
45. Wermke W. Sonographische Differenzialdiagnose. Leberkrankheiten. Köln, Deutscher Ärzteverlag 2005
46. Xie L, Guang Y, Ding H et al. Diagnostic value of contrast-enhanced ultrasound, computed tomography and magnetic resonance imaging for focal liver lesions: a meta-analysis. Ultrasound Med Biol 2011;37:854-861
47. Young NA, Mody DR, Davey DD. Misinterpretation of normal cellular elements in fine-needle aspiration biopsy specimens: observations from the College of American Pathologists Interlaboratory Comparison Program in Non-Gynecologic Cytopathology. Arch Pathol Lab Med 2002;126:670-675
48. Zech CJ. Mit welcher Methode? Sichere Diagnose bei einem Zufallsbefund in der Leber. MMW Fortschr Med 2011;153:41-44